TR200103231T2 - Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì - Google Patents

Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì

Info

Publication number
TR200103231T2
TR200103231T2 TR2001/03231T TR200103231T TR200103231T2 TR 200103231 T2 TR200103231 T2 TR 200103231T2 TR 2001/03231 T TR2001/03231 T TR 2001/03231T TR 200103231 T TR200103231 T TR 200103231T TR 200103231 T2 TR200103231 T2 TR 200103231T2
Authority
TR
Turkey
Prior art keywords
lipoglycan
treating
compounds
methods
parasitic infections
Prior art date
Application number
TR2001/03231T
Other languages
English (en)
Inventor
H. Semprevivo Lyoyd
Original Assignee
University Of Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Massachusetts filed Critical University Of Massachusetts
Publication of TR200103231T2 publication Critical patent/TR200103231T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bir omurgal da bir ökaryot parazite karç koruyucu bir baG ç kl k tepkisi ortaya ç karmak için bir bileçim ve bunun bir metotu ortaya konmaktad r. Metot bir ökaryotun yüzeyinde bulunan bir lipoglikandan elde edilen bir oligosakarite eçlenmiç bir taç y c grup içeren bir bileçimi omurgal ya uygulamay içermektedir. Bileçim parazite karç koruyucu bir baG ç kl k tepkisi ortaya ç kartmaya yetecek bir miktarda uygulanmaktad r.
TR2001/03231T 1999-03-12 2000-03-10 Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì TR200103231T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
TR200103231T2 true TR200103231T2 (tr) 2002-03-21

Family

ID=22411778

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2002/02066T TR200202066T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları
TR2002/02078T TR200202078T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları
TR2001/03231T TR200103231T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TR2002/02066T TR200202066T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları
TR2002/02078T TR200202078T2 (tr) 1999-03-12 2000-03-10 Lipoglikan bileşimleri ve parazit enfeksiyonlarını tedavi etme metotları

Country Status (17)

Country Link
US (3) US6428793B1 (tr)
EP (1) EP1175226B1 (tr)
JP (1) JP2002538220A (tr)
AT (1) ATE439857T1 (tr)
AU (1) AU771373B2 (tr)
BR (1) BR0008949A (tr)
CA (1) CA2364507A1 (tr)
DE (1) DE60042776D1 (tr)
HU (1) HUP0200466A3 (tr)
MA (1) MA25347A1 (tr)
MX (1) MXPA01009206A (tr)
NO (1) NO20014411L (tr)
NZ (1) NZ514112A (tr)
PL (1) PL203789B1 (tr)
TR (3) TR200202066T2 (tr)
WO (1) WO2000053220A1 (tr)
ZA (1) ZA200107502B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
EP2494980A3 (en) * 2009-10-21 2013-03-13 ETH Zurich Medical utility of glycans

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
AU5928999A (en) * 1998-09-21 2000-04-10 Richard D. Cummings Assays for helminth infections

Also Published As

Publication number Publication date
BR0008949A (pt) 2002-09-24
TR200202066T2 (tr) 2004-12-21
PL203789B1 (pl) 2009-11-30
US20020160021A1 (en) 2002-10-31
NO20014411D0 (no) 2001-09-11
PL350989A1 (en) 2003-02-24
US7204983B2 (en) 2007-04-17
EP1175226A1 (en) 2002-01-30
TR200202078T2 (tr) 2002-11-21
US6428793B1 (en) 2002-08-06
CA2364507A1 (en) 2000-09-14
EP1175226A4 (en) 2005-01-05
HUP0200466A2 (en) 2002-06-29
WO2000053220A1 (en) 2000-09-14
EP1175226B1 (en) 2009-08-19
AU771373B2 (en) 2004-03-18
ZA200107502B (en) 2003-02-26
DE60042776D1 (de) 2009-10-01
HUP0200466A3 (en) 2006-11-28
NO20014411L (no) 2001-11-09
AU3625100A (en) 2000-09-28
US7063848B2 (en) 2006-06-20
JP2002538220A (ja) 2002-11-12
MXPA01009206A (es) 2003-07-14
NZ514112A (en) 2003-08-29
MA25347A1 (fr) 2001-12-31
ATE439857T1 (de) 2009-09-15
US20060228382A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
DK0865297T3 (da) Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
FR2771291B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques
FI973492A0 (fi) NO-syntaasin estäjät
DK0646006T3 (da) Stabile præparater af gastrobeskyttede omeprazolmikrogranuler og fremgangsmåde til opnåelse deraf
NO963447L (no) Transdermale, terapeutiske systemer som inneholder seksualsteroider
AR003989A1 (es) Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica.
WO2002049593A3 (de) Verwendung von dna-reparatur-enzymen als mmp-1-inhibitoren
DK0773025T3 (da) Nye stabile galeniske formuleringer indeholdende en syrelabil benzimidazolforbindelser, og fremgangsmåde til fremstilling
NO985148L (no) FremgangsmÕte og formuleringer til Õ forhindre og/eller behandle alle infek
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
EP0119161A3 (en) Benzazoquinone and benzazoninone derivatives, process for their preparation, their pharmaceutical preparations as well as their therapeutic use
PT692028E (pt) Farmacos baseados em papilomavirus
WO1999063978A3 (en) Methods of treating microbial infection and therapeutic formulations therefor
IT1285398B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
TR200103231T2 (tr) Lipoglikan bileçimleri ve parazit enfeksiyonlarìnì tedavi etme metotlarì
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
DE69325174D1 (de) Ophthalmische zusammensetzungen und verfahren zu ihrer konservierung und anwendung
AU2942900A (en) Method of accessing internet using two-dimensional code and system for pinpoint access to internet
PT757556E (pt) Bacterina borrelia burgdorferi
AU2001248491A1 (en) Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials
DE69800804T2 (de) Halbfeste pharmazeutische zubereitungen enthaltend dexketoprofen-trometamol
DE69509643T2 (de) Sesquiterpenderivate
HU9301217D0 (en) Antiseptic active agent of herb extract and method for obtaining it
WO1996027384A3 (en) Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase
DE69532973D1 (de) Orthogonalcodevielfachzugriffsystem mit mehrwegunterdrückung